ENHANCED IMMUNOGENICITY OF PROTEIN-DEXTRAN CONJUGATES .1. RAPID STIMULATION OF ENHANCED ANTIBODY-RESPONSES TO POORLY IMMUNOGENIC MOLECULES

被引:31
作者
LEES, A [1 ]
FINKELMAN, F [1 ]
INMAN, JK [1 ]
WITHERSPOON, K [1 ]
JOHNSON, P [1 ]
KENNEDY, J [1 ]
MOND, JJ [1 ]
机构
[1] NIAID,IMMUNOL LAB,BETHESDA,MD 20892
关键词
PROTEIN-DEXTRAN CONJUGATES; IMMUNOGENICITY; ENHANCED RESPONSE;
D O I
10.1016/0264-410X(94)90237-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In view of our observation that anti-immunoglobulin antibody conjugated to high-molecular-weight dextran stimulates high levels of B-cell activation (Brunswick et al. J. Immunol. 1989, 143, 1239), we coupled T cell-dependent antigens to dextran. When mice were immunized, in the absence of adjuvant, with a BSA-dextran conjugate (BSA-dex), a persistent, high-titre anti-BSA IgG1 response was induced. Titres were dose-dependent and seen with as little as 10 mu g of conjugated protein. Anti-BSA titres were detected as early as day 7, usually peaked at about day 14 and persisted for at least 4 weeks. Anti-hapten antibodies were also elicited in mice that were immunized with haptenated BSA covalently bound to dextran, and secondary responses could be induced even after inoculation of the unconjugated protein. Covalent attachment of the protein to the polymer was necessary, and the response was specific, as coinjection of BSA-dex and an unrelated antigen, goat IgG, did not elicit detectable anti-goat antibodies. The immunogenic potential of these conjugates did not depend on the ability of the dextran carrier to induce antibody, inasmuch as they stimulated high levels of anti-protein antibody in mice unresponsive to dextran. A minimum size dextran polymer was required for 2000 kDa but not of 70 kDa gave detectable anti-BSA titres.
引用
收藏
页码:1160 / 1166
页数:7
相关论文
共 34 条
[1]   ANTIBODY-RESPONSES TO HEMOPHILUS-INFLUENZAE TYPE B AND DIPHTHERIA-TOXIN INDUCED BY CONJUGATES OF OLIGOSACCHARIDES OF THE TYPE-B CAPSULE WITH THE NONTOXIC PROTEIN CRM197 [J].
ANDERSON, P .
INFECTION AND IMMUNITY, 1983, 39 (01) :233-238
[2]  
AUGISTIN AA, 1980, J EXP MED, V151, P387
[3]  
AVERY OT, 1929, J EXP MED, V50, P521
[4]  
BOTTGER EC, 1985, J IMMUNOL, V135, P4100
[5]  
BRUNSWICK M, 1988, J IMMUNOL, V140, P3364
[6]  
Cruse J. M, 1989, CONJUGATE VACCINES, V10
[7]   MAJOR HISTOCOMPATIBILITY COMPLEX INDEPENDENT T-CELL RECEPTOR-ANTIGEN INTERACTION - FUNCTIONAL-ANALYSIS USING FLUORESCEIN DERIVATIVES [J].
DIAMOND, DJ ;
SZALAY, P ;
SYMER, D ;
HAO, P ;
SHIN, HS ;
DINTZIS, RZ ;
DINTZIS, HM ;
REINHERZ, EL ;
SILICIANO, RF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :229-241
[8]  
DINTZIS RZ, 1989, J IMMUNOL, V143, P1239
[9]  
FELDMAN M, 1971, J EXP MED, V136, P103
[10]  
FINKELMAN FD, 1982, J IMMUNOL, V129, P629